Correlation of Ferritin Serum With Estimated Glomerular Filtration Rate in Adult Beta Thalassemia Major Patients

Authors

  • Immanuel Andriantono Universitas Airlangga, Indonesia
  • Pradana Zaky Romadhon Universitas Airlangga
  • Satriyo Dwi Suryantoro Universitas Airlangga
  • Aditea Etnawati Putri Universitas Airlangga

DOI:

https://doi.org/10.58344/locus.v4i6.4099

Keywords:

Beta Thalassemia Major, Serum Ferritin, eGFR

Abstract

Patients suffering from beta thalassemia major experienced iron overload due to hemolysis, increased iron absorption in the gastrointestinal tract, and primarily due to repeated blood transfusions. This iron accumulation was exacerbated by the lack of a physiological mechanism for the body to naturally eliminate excess iron. One of the main complications of this condition was iron toxicity, which could damage various organs, including causing renal dysfunction. The persistence of this condition was associated with an increased risk of kidney injury, which could potentially lead to acute kidney injury and renal complications. The objective of the present study was to ascertain the correlation between serum ferritin levels and eGFR in adult patients diagnosed with beta thalassemia major in order to achieve the third focus of Sustainable Development Goals (SGD’s) in good health and well-being. The present study was a quantitative research study that utilized an observational analytic design with a cross-sectional approach. It was based on secondary data from the medical records of adult patients with beta thalassemia major at the Department of Internal Medicine, Universitas Airlangga Hospital. Subjects were selected using consecutive sampling. The statistical analysis of the correlation between serum ferritin levels and eGFR was conducted using Spearman tests. A total of 62 adult patients with beta thalassemia major were include this study, with mean age of 26 years. The majority of participants (42 patients or 67,7%) had serum ferritin levels below 1000 ?g/L. All of Subjects (62 patients) had eGFR within the normal range, all were classified as G1 (> 90 mL/min/1.73 m²). The Spearman analysis results showed a weak positive correlation between serum ferritin levels and eGFR with a correlation coefficient (r = 0.277) and a p-value of 0.029. Conclusion: There is a weak positive correlation between serum ferritin levels and eGFR in adult patients with beta thalassemia major.

References

Al Tameemi WF, Altawry ZMJ. Earlier Detection of Glomerular Dysfunction in ?-Thalassemia Major Patients. Thalass Reports [Internet]. 2020 Jun 3;10(1):9007. Available from: https://www.mdpi.com/2039-4365/10/1/9007

Al-Hafidh, N.M., Younis, M.S., Taee, K.F. Al, n.d. Survival rate and mortality causes in patients with ?-thalassemia major in Nineveh Governorate, Iraq 14.

Ali EA, Albayati AA, Alshaban SA, Althamer KA. Serum hepcidin and ferritin level changes in iraqi adult patients with non-transfusion dependent beta-thalassemia major and intermedia. Int J Pharm Res. 2020;13(1):1373–8.

Ali, B.A., Mahmoud, A.M., 2014. Frequency of glomerular dysfunction in children with Beta thalassaemia major. Sultan Qaboos Univ Med J 14. https://doi.org/10.12816/0003341

Al-Zwaini, I.J. (2018) ‘Introductory chapter: Thalassemia - an overview’, Thalassemia and Other Hemolytic Anemias [Preprint]. doi:10.5772/intechopen.77375.

Atmakusuma TD, Hasibuan FD, Purnamasari D. The correlation between iron overload and endocrine function in adult transfusion-dependent beta-thalassemia patients with growth retardation. J Blood Med. 2021;12(July):749–53.

Bakr, A., Al-Tonbary, Y., Osman, G., El-Ashry, R., 2014. Renal complications of beta-thalassemia major in children. Am J Blood Res 4, 1.

Crichton, R. (2019) ‘Intracellular metabolism and homeostasis of metal ions’, Biological Inorganic Chemistry, pp. 207–259. doi:10.1016/b978-0-12-811741-5.00008-4.

Dasgupta, A. and Wahed, A. (2021a) ‘Hemoglobinopathies and thalassemia’, in Clinical Chemistry, Immunology and Laboratory Quality Control. Elsevier, pp. 457–487. doi: 10.1016/B978-0-12-815960-6.00005-4

Demosthenous, C., Eleftheriou, P., Apostolou, C., Sarafidis, P., Perifanis, V., Vlachaki, E., 2018. ?-Thalassemia and renal complications. A narrative review of pathophysiologic mechanisms. Integr Mol Med 5. https://doi.org/10.15761/IMM.1000340

Fernandes, J.L. (2018) ‘MRI for iron overload in thalassemia’, Hematology/Oncology Clinics of North America, 32(2), pp. 277–295. doi:10.1016/j.hoc.2017.11.012.

Forni, G. L., Gianesin, B., Musallam, K. M., Longo, F., Rosso, R., Lisi, R., Gamberini, M. R., Pinto, V. M., Graziadei, G., Vitucci, A., Bonetti, F., Musto,

P., Piga, A., Cappellini, M. D., & Borgna-Pignatti, C. (2023). Overall and complication?free survival in a large cohort of patients with ??thalassemia major followed over 50?years. American Journal of Hematology/Oncology, 98(3), 381–387. https://doi.org/10.1002/AJH.26798

Mahmoud, A.A. et al. (2021) ‘Assessment of subclinical renal glomerular and tubular dysfunction in children with beta thalassemia major’, Children, 8(2), p. 100. doi:10.3390/children8020100.

Milo, G. et al. (2015) ‘GFR in patients with ?-thalassemia major’, Clinical Journal of the American Society of Nephrology, 10(8), pp. 1350–1356. doi:10.2215/cjn.12181214.

Modell, B., Khan, M., & Darlison, M. (2000). Survival in ?-thalassaemia major in the UK: data from the UK Thalassaemia Register. The Lancet, 355(9220), 2051–2052. https://doi.org/10.1016/S0140-6736(00)02357-6

Mohajeri-Tehrani, M. R., Alemzadeh, S. A., Marzbali, F. A., Nasserisina, S., Hosnan, F., Naghghash, A., Hamidieh, A. A., Behfar, M., Mohseni, F., Rashidian, H., Shirazi, S., Aboee-Rad, M., Qorbani, M., Larijani, B., & Hamidi, Z. (2024). How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients. Iranian Journal of Public Health, 53(2), 433–442. https://doi.org/10.18502/IJPH.V53I2.14928

Hassan, T. and Zakaria, M. (2020) ‘Updates in Thalassemia’, Beta Thalassemia [Preprint]. doi:10.5772/intechopen.92414.

Ibrahim AS, Abd El-Fatah AH, Abd El-Halim AF, Mohamed FF. Serum Ferritin Levels and Other Associated Parameters with Diabetes Mellitus in Adult Patients Suffering from Beta Thalassemia Major. J Blood Med. 2023;Volume 14(February):67–81.

Keohane, E. M. (2020) ‘Thalassemias’, in Rodak’s Hematology. Elsevier, pp. 424–444. doi: 10.1016/B978-0-323-53045-3.00034-9.

Khandker SS, Jannat N, Sarkar D, Pranto AH, Hoque IA, Zaman J, et al. Association between Glomerular Filtration Rate and ?-Thalassemia Major: A Systematic Review and Meta-Analysis. Thalass Reports. 2023;13(3):195–205.

Knovich, M. A. et al. (2009) ‘Ferritin for the clinician’, Blood Reviews, 23(3), pp. 95–104. doi: 10.1016/j.blre.2008.08.001.

Koonyosying, P., Fucharoen, S. and Srichairatanakool, S. (2020) ‘Nutraceutical benefits of green tea in beta-thalassemia with iron overload’, Beta Thalassemia [Preprint]. doi:10.5772/intechopen.92970.

Lai ME, Spiga A, Vacquer S, Carta MP, Corrias C, Ponticelli C. Renal function in patients with ?-thalassaemia major: A long-term follow-up study. Nephrol Dial Transplant. 2012;27(9):3547–51.

Ndrepepa, G. (2023) ‘De Ritis ratio and cardiovascular disease: evidence and underlying mechanisms’, Journal of Laboratory and Precision Medicine, 8, pp. 1–24. doi: 10.21037/JLPM-22-68.

Nienhuis, A.W., Nathan, D.G., 2012. Pathophysiology and Clinical Manifestations of the ?-Thalassemias. Cold Spring Harb Perspect Med 2. https://doi.org/10.1101/CSHPERSPECT.A011726

Permadi SS, Renarti L, Rachmadi D. Correlation between Serum Ferritin , Serum Cystatin C , and Renal Function in Children with ? Thalassemia Major Hubungan Feritin dan Cystatin C Serum dengan Fungsi Ginjal pada Anak Talasemia ? Mayor. Maj Kedokt Bandung. 2019;51(38):160–4.

Pimentel, L. L. et al. (2019) Clinical analysis | enzymes in physiological samples. 3rd edn, Encyclopedia of Analytical Science. 3rd edn. Elsevier Inc. doi: 10.1016/B978-0-12-409547-2.14270-2.

Premawardhena, A.P., Ediriweera, D.S., Sabouhanian, A., Allen, A., Rees, D., de Silva, S., Perera, W., Katugaha, N., Arambepola, M., Yamashita, R.C., Mettananda, S., Jiffry, N., Mehta, V., Cader, R., Bandara, D., St Pierre, T., Muraca, G., Fisher, C., Kirubarajan, A., Khan, S., Allen, S., Lamabadusuriya, S.P., Weatherall, D.J., Olivieri, N.F., 2022. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study. Lancet Glob Health 10, e134–e141. https://doi.org/10.1016/S2214-109X(21)00446-0

Renal failure in thalassemia: Thinking outside the box, 2020. https://doi.org/10.1002/ccr3.2738

Shah F, Huey K, Deshpande S, Turner M, Chitnis M, Schiller E, et al. Relationship between Serum Ferritin and Outcomes in ?-Thalassemia: A Systematic Literature Review. J Clin Med. 2022;11(15).

Shah, F. T. et al. (2019) ‘Challenges of blood transfusions in ?-thalassemia’, Blood Reviews, 37, p. 100588. doi: 10.1016/j.blre.2019.100588.

Siregar, O.R., Siregar, R.S. and Lubis, B. (2020) ‘Renal function in children with ?-thalassemia major treated with iron chelating agent’, The Indonesian Biomedical Journal, 12(3), pp. 214–9. doi:10.18585/inabj.v12i3.1053.

Romadhon, P.Z. et al. (2022) ‘Markers of renal complications in beta thalassemia patients with iron overload receiving chelation agent therapy: A systematic review’, Journal of Blood Medicine, Volume 13, pp. 725–738. doi:10.2147/jbm.s387416.

Takpradit C, Viprakasit V, Narkbunnam N, Vathana N, Phuakpet K, Pongtanakul B, et al. Using of deferasirox and deferoxamine in refractory iron overload thalassemia. Pediatr Int [Internet]. 2021 Apr 29;63(4):404–9. Available from: https://onlinelibrary.wiley.com/doi/10.1111/ped.14444

Tanous O, Azulay Y, Halevy R, Dujovny T, Swartz N, Colodner R, et al. Renal function in ?-thalassemia major patients treated with two different iron-chelation regimes. BMC Nephrol [Internet]. 2021;22(1):1–11. Available from: https://doi.org/10.1186/s12882-021-02630-5

Tatu, T. (2020) ‘Laboratory Diagnosis of ?-Thalassemia and HbE’, in Beta Thalassemia. IntechOpen. doi: 10.5772/intechopen.90317.

Wahed, A., Quesada, A. and Dasgupta, A. (2020) ‘Hemoglobinopathies and thalassemias’, in Hematology and Coagulation. Elsevier, pp. 51–75. doi: 10.1016/B978-0-12-814964-5.00004-8.

Wahidiyat, P.A., Sari, T.T., Rahmartani, L.D., Iskandar, S.D., Pratanata, A.M., Yapiy, I., Setianingsih, I., Atmakusuma, T.D., Lubis, A.M., 2022. Thalassemia in Indonesia. Hemoglobin 46, 39–44. https://doi.org/10.1080/03630269.2021.2023565

Xu, X., Wu, X., 2020. Epidemiology and treatment of beta thalassemia major in China. Pediatr Investig 4, 43. https://doi.org/10.1002/PED4.12154

Yadav, P.K., Singh, A.K., 2022. A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets. Plasmatology 16. https://doi.org/10.1177/26348535221103560/ASSET/IMAGES/LARGE/10.1177_26348535221103560-FIG1.JPEG

Zahira, A. F. (2022) Korelasi antara Kadar Serum Feritin dengan Kadar Enzim Aspartat Aminotransferase (AST) dan Alanin Aminotransferase (ALT) pada Pasien B-Thalassemia Mayor dengan Transfusi Darah Berulang di RSUD Dr. Soetomo. Universitas Airlangga.

Zakaria, M. and Hassan, T. (2020) ‘Introductory chapter: ?-thalassemia’, Beta Thalassemia [Preprint]. doi:10.5772/intechopen.90946.

Downloads

Published

2025-06-28

Issue

Vol. 4 No. 6 (2025): JURNAL LOCUS: Penelitian & Pengabdian

Section

Articles

License

Copyright (c) 2025 Immanuel Andriantono, Pradana Zaky Romadhon, Satriyo Dwi Suryantoro, Aditea Etnawati Putri

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.